# Protective Effects of Thyme Leaf Extract Against Particulate Matter-Induced Pulmonary Injury in Mice

**Authors:** Jae-Kyoung Lee, Khawaja Muhammad Imran Bashir, Hye-Rim Park, Jin-Gwan Kwon, Beom-Rak Choi, Jae-Suk Choi, Sae-Kwang Ku

PMC · DOI: 10.3390/antiox14111343 · 2025-11-07

## TL;DR

This study shows that thyme extract can protect mice from lung damage caused by air pollution particles, with effects similar to a common anti-inflammatory drug.

## Contribution

The study demonstrates the dose-dependent protective effects of thyme extract against PM2.5-induced lung injury in mice.

## Key findings

- Thyme extract reduced inflammation, oxidative stress, and mucus production in PM2.5-exposed mice.
- Thyme extract improved lung pathology and antioxidant defenses without causing liver damage.
- Thyme extract showed expectorant activity and reduced mucus hyperplasia more effectively than dexamethasone.

## Abstract

Airborne particulate matter (PM), particularly PM2.5, contributes to pulmonary injury by inducing oxidative stress and inflammation. Thyme (Thymus vulgaris L.) contains bioactive compounds with anti-inflammatory, antioxidant, and expectorant properties. Here, we evaluated the dose-dependent protective effects of thyme extract (TV) against PM2.5-induced pulmonary injury in mice, using dexamethasone (DEXA) as a reference anti-inflammatory drug. Subacute pulmonary injury was induced in male Balb/c mice via intranasal administration of PM2.5 (1 mg/kg, twice at 48 h intervals). Mice received oral TV (50, 100, or 200 mg/kg) or DEXA (0.75 mg/kg) daily for 10 days. Assessments included lung weight, serum AST/ALT, bronchoalveolar lavage fluid (BALF) leukocyte counts, cytokines (TNF-α, IL-6), chemokines, oxidative stress markers (ROS, lipid peroxidation, antioxidant enzymes), histopathology, and mRNA expression of genes related to inflammation (PI3K/Akt, MAPK, and NF-κB), mucus production (MUC5AC, MUC5B), and apoptosis (Bcl-2, Bax). Exposure to PM2.5 caused oxidative stress, pulmonary inflammation, mucus hypersecretion, and histopathological changes. TV treatment dose-dependently reduced leukocyte infiltration, cytokine/chemokine release, ROS generation, and mucus overproduction, while enhancing antioxidant defenses and improving tissue pathology. Effects were comparable but slightly less potent than DEXA. Notably, unlike DEXA, TV reduced mucus hyperplasia and enhanced expectorant activity. No hepatotoxicity was observed. These results indicate that thyme extract could serve as a promising natural candidate for alternative respiratory therapeutics or functional food development.

## Linked entities

- **Genes:** PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 5290], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207], MAPK (mitogen activated kinase-like protein) [NCBI Gene 7446652], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790], MUC5AC (mucin 5AC, oligomeric mucus/gel-forming) [NCBI Gene 4586], MUC5B (mucin 5B, oligomeric mucus/gel-forming) [NCBI Gene 727897], BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596], BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581]
- **Proteins:** TNF (tumor necrosis factor), IL6 (interleukin 6), ROS1 (ROS proto-oncogene 1, receptor tyrosine kinase), BCL2 (BCL2 apoptosis regulator), BAX (BCL2 associated X, apoptosis regulator)
- **Chemicals:** dexamethasone (PubChem CID 5743)

## Full-text entities

- **Genes:** Muc5ac (mucin 5, subtypes A and C, tracheobronchial/gastric) [NCBI Gene 17833] {aka 2210005L13Rik, MGM}, Muc5b (mucin 5, subtype B, tracheobronchial) [NCBI Gene 74180] {aka 2300002I04Rik, A130042M24, MUC5, MUC9, mucin 5b}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Bax (BCL2-associated X protein) [NCBI Gene 12028], Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Bcl2 (B cell leukemia/lymphoma 2) [NCBI Gene 12043] {aka Bcl-2, C430015F12Rik, D630044D05Rik, D830018M01Rik}, Gpt (glutamic pyruvic transaminase, soluble) [NCBI Gene 76282] {aka 1300007J06Rik, 2310022B03Rik, ALT, ALT1, Gpt-1, Gpt1}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Slc17a5 (solute carrier family 17 (anion/sugar transporter), member 5) [NCBI Gene 235504] {aka 4631416G20Rik, 4732491M05, AST, ISSD, NSD, SD}
- **Diseases:** pulmonary inflammation (MESH:D011014), inflammation (MESH:D007249), Pulmonary Injury (MESH:D055370), mucus hyperplasia (MESH:D006965)
- **Chemicals:** lipid (MESH:D008055), PM2.5 (-), DEXA (MESH:D003907)
- **Species:** Thymus vulgaris (common thyme, species) [taxon 49992], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** Balb/c — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0184)

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12649178/full.md

---
Source: https://tomesphere.com/paper/PMC12649178